Uncover key drivers, emerging technologies, and competitive movements shaping the food allergy treatment market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Food Allergy Treatment Market show for the 2026–2030 period?
The food allergy treatment market size has seen rapid expansion in recent years. It is projected to expand from $7.6 billion in 2025 to $8.5 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.8%. Historically, this market’s growth can be linked to an increase in food allergy prevalence, the accessibility of antihistamines, wider adoption of epinephrine therapy, enhanced allergy diagnosis rates, and the evolution of clinical guidelines.
The food allergy treatment market size is anticipated to undergo significant growth in the upcoming years. It is projected to expand to $12.73 billion in 2030, achieving a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is attributable to innovation in oral immunotherapy, the expansion of biologic treatments, an increase in pediatric allergy care, the rising demand for long-term allergy management, and improving healthcare access. Major trends expected in the forecast period include the increasing adoption of immunotherapy-based treatments, a rise in the use of epinephrine auto-injectors, an intensifying focus on preventive allergy management, the broadening of personalized allergy treatment plans, and heightened awareness of food allergy conditions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16684&type=smp
What Drivers Are Shaping The Development Of The Food Allergy Treatment Market?
The rising incidence of food adulteration is anticipated to fuel the expansion of the food allergy treatment market moving forward. Food adulteration entails the deliberate manipulation of food products, either by introducing inferior, harmful, or unauthorized substances, or by removing valuable ingredients, with the aim of increasing quantity or enhancing appearance, often at the detriment of quality and safety. This practice is on the rise due to various factors, including the pursuit of economic gain, the complexity of supply chains, insufficient regulatory frameworks, technological advancements, the demand for convenience, globalization, environmental influences, consumer awareness, favorable profit margins, and inadequate enforcement of regulations. A key driver for the growth in food adulteration is the escalating demand for cheaper products, which encourages producers to cut costs and maximize profits through unethical means. Such adulteration can heighten the risk of allergic reactions by introducing allergens into food items or by compromising the overall safety and integrity of the food supply. For instance, in 2023, the FDA CORE Network, a U.S.-based government agency, reported that its team evaluated 69 incidents, responded to 25, and issued 10 public health advisories, a change from 65 incidents, 28 responses, and 11 advisories in 2022. Consequently, the increasing prevalence of food adulteration is a significant force propelling the growth of the food allergy treatment market.
What Segment Types Are Examined In The Food Allergy Treatment Market?
The food allergy treatment market covered in this report is segmented –
1) By Drug Type: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anti-Cholinergic, Immuno-Modulators, Epinephrine, Immunotherapy
2) By Route Of Administration: Parenteral, Oral
3) By Allergen Type: Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other Allergens
4) By End-Use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses
Subsegments:
1) By Antihistamines: Oral Antihistamines, Topical Antihistamines, Intranasal Antihistamines
2) By Decongestants: Oral Decongestants, Nasal Decongestants
3) By Corticosteroids: Oral Corticosteroids, Topical Corticosteroids, Intranasal Corticosteroids
4) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil
5) By Leukotriene Inhibitors: Montelukast, Zafirlukast
6) By Nasal Anti-Cholinergic: Ipratropium Bromide
7) By Immuno-Modulators: Omalizumab, Dupilumab
8) By Epinephrine: Injectable Epinephrine, Auto-Injectors
9) By Immunotherapy: Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT)
What Industry Trends Are Transforming The Food Allergy Treatment Market?
Leading companies in the food allergy treatment market are innovating therapies, such as monoclonal antibodies, to address the core mechanisms of food allergies and offer more effective patient treatments. Monoclonal antibodies present a promising method for treating food allergies by targeting specific immune system components involved in allergic reactions, providing more effective and precise treatments for patients. For instance, in February 2024, Novartis AG, a Switzerland-based pharmaceutical company, received FDA approval for Xolair (omalizumab) to diminish IgE-mediated food allergies. This humanized monoclonal antibody, administered subcutaneously, functions by inhibiting the binding of IgE antibodies, thereby reducing the release of chemicals responsible for allergy symptoms. The FDA approval is grounded in positive data from the Phase III OUtMATCH study, which indicated that a significantly higher proportion of food allergy patients, as young as 1 year, treated with Xolair could tolerate small amounts of peanut, milk, egg, and cashews without an allergic reaction when compared to a placebo.
Who Are The Primary Competitors In The Global Food Allergy Treatment Market?
Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/food-allergy-treatment-global-market-report
Which Regions Are Projected To Dominate The Food Allergy Treatment Market In The Coming Years?
North America was the largest region in the food allergy treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Food Allergy Treatment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16684&type=smp
Browse Through More Reports Similar to the Global Food Allergy Treatment Market 2026, By The Business Research Company
Allergy Immunotherapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report
Allergy Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report
Peanut Allergy Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/peanut-allergy-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model